Abstract

Gene regulatory networks coordinate the formation of organs and structures that compose the evolving body plans of different organisms. We are using a simple chordate model, the Ciona embryo, to investigate the essential gene regulatory network that orchestrates morphogenesis of the notochord, a structure necessary for the proper development of all chordate embryos. Although numerous transcription factors expressed in the notochord have been identified in different chordates, several of them remain to be positioned within a regulatory framework. Here we focus on Xbp1, a transcription factor expressed during notochord formation in Ciona and other chordates. Through the identification of Xbp1-downstream notochord genes in Ciona, we found evidence of the early co-option of genes involved in the unfolded protein response to the notochord developmental program. We report the regulatory interplay between Xbp1 and Brachyury, and by extending these results to Xenopus, we show that Brachyury and Xbp1 form a cross-regulatory subcircuit of the notochord gene regulatory network that has been consolidated during chordate evolution.

Data availability

The complete dataset has been deposited into the NCBI Gene Expression Omnibus, under accession number GSE46751

The following data sets were generated

Article and author information

Author details

  1. Yushi Wu

    Department of Molecular Pathobiology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Arun Devotta

    Department of Molecular Pathobiology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Diana S José-Edwards

    Department of Molecular Pathobiology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Jamie E Kugler

    Department of Molecular Pathobiology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Lenny J Negrón-Piñeiro

    Department of Molecular Pathobiology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Karina Braslavskaya

    Department of Molecular Pathobiology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Jermyn Addy

    Department of Molecular Pathobiology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Jean-Pierre Saint-Jeannet

    Department of Molecular Pathobiology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3259-2103
  9. Anna Di Gregorio

    Department of Molecular Pathobiology, New York University, New York, United States
    For correspondence
    adg13@nyu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4089-7484

Funding

National Institutes of Health (R03HD098395)

  • Yushi Wu
  • Arun Devotta
  • Diana S José-Edwards
  • Jamie E Kugler
  • Lenny J Negrón-Piñeiro
  • Karina Braslavskaya
  • Jermyn Addy
  • Anna Di Gregorio

National Institutes of Health (graduate student training grant,T32HD007520)

  • Lenny J Negrón-Piñeiro

National Institutes of Health (graduate student training grant,T32GM008539)

  • Diana S José-Edwards

National Institutes of Health (Administrative supplement R03HD098395-02S1)

  • Lenny J Negrón-Piñeiro

New York University Center for Skeletal and Craniofacial Biology (Pilot grant)

  • Yushi Wu
  • Arun Devotta
  • Diana S José-Edwards
  • Jamie E Kugler
  • Lenny J Negrón-Piñeiro
  • Karina Braslavskaya
  • Jermyn Addy
  • Jean-Pierre Saint-Jeannet
  • Anna Di Gregorio

National Institutes of Health (Center Core Grant for the NYU CSCB 1P30DE020754)

  • Jean-Pierre Saint-Jeannet

National Institutes of Health (Center Grant for NYU Langone Health DART Microscopy Laboratory P30CA016087)

  • Yushi Wu
  • Anna Di Gregorio

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Procedure minimizing discomfort and pain - only applicable to XenopusThe collection of eggs from females primed with chorionic gonadotropin hormone requires minimum procedures occasioning virtually no pain or suffering. Surgical dissection of the testes is performed on euthanized males (see below), preventing discomfort.Methods of euthanasiaMale frogs will be euthanized during the procedure, in a two-step process. They will be initially anesthetized by immersion into a solution of ethyl amino benzoate (tricaine/MS222) and then a pithing procedure of the brain and the spinal cord will be used to terminate the animal. After pithing, respiration ceases signaling death. Female frogs will be euthanized in a similar manner when no longer producing viable eggs or appear ill.

Copyright

© 2022, Wu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,184
    views
  • 212
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yushi Wu
  2. Arun Devotta
  3. Diana S José-Edwards
  4. Jamie E Kugler
  5. Lenny J Negrón-Piñeiro
  6. Karina Braslavskaya
  7. Jermyn Addy
  8. Jean-Pierre Saint-Jeannet
  9. Anna Di Gregorio
(2022)
Xbp1 and Brachyury establish an evolutionarily conserved subcircuit of the notochord gene regulatory network
eLife 11:e73992.
https://doi.org/10.7554/eLife.73992

Share this article

https://doi.org/10.7554/eLife.73992

Further reading

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Thi Thom Mac, Teddy Fauquier ... Thierry Brue
    Research Article

    Deficient Anterior pituitary with common Variable Immune Deficiency (DAVID) syndrome results from NFKB2 heterozygous mutations, causing adrenocorticotropic hormone deficiency (ACTHD) and primary hypogammaglobulinemia. While NFKB signaling plays a crucial role in the immune system, its connection to endocrine symptoms is unclear. We established a human disease model to investigate the role of NFKB2 in pituitary development by creating pituitary organoids from CRISPR/Cas9-edited human induced pluripotent stem cells (hiPSCs). Introducing homozygous TBX19K146R/K146R missense pathogenic variant in hiPSC, an allele found in congenital isolated ACTHD, led to a strong reduction of corticotrophs number in pituitary organoids. Then, we characterized the development of organoids harboring NFKB2D865G/D865G mutations found in DAVID patients. NFKB2D865G/D865G mutation acted at different levels of development with mutant organoids displaying changes in the expression of genes involved on pituitary progenitor generation (HESX1, PITX1, LHX3), hypothalamic secreted factors (BMP4, FGF8, FGF10), epithelial-to-mesenchymal transition, lineage precursors development (TBX19, POU1F1) and corticotrophs terminal differentiation (PCSK1, POMC), and showed drastic reduction in the number of corticotrophs. Our results provide strong evidence for the direct role of NFKB2 mutations in the endocrine phenotype observed in patients leading to a new classification of a NFKB2 variant of previously unknown clinical significance as pathogenic in pituitary development.

    1. Developmental Biology
    2. Genetics and Genomics
    Debashish U Menon, Prabuddha Chakraborty ... Terry Magnuson
    Research Article

    We present evidence implicating the BAF (BRG1/BRM Associated Factor) chromatin remodeler in meiotic sex chromosome inactivation (MSCI). By immunofluorescence (IF), the putative BAF DNA binding subunit, ARID1A (AT-rich Interaction Domain 1 a), appeared enriched on the male sex chromosomes during diplonema of meiosis I. Germ cells showing a Cre-induced loss of ARID1A arrested in pachynema and failed to repress sex-linked genes, indicating a defective MSCI. Mutant sex chromosomes displayed an abnormal presence of elongating RNA polymerase II coupled with an overall increase in chromatin accessibility detectable by ATAC-seq. We identified a role for ARID1A in promoting the preferential enrichment of the histone variant, H3.3, on the sex chromosomes, a known hallmark of MSCI. Without ARID1A, the sex chromosomes appeared depleted of H3.3 at levels resembling autosomes. Higher resolution analyses by CUT&RUN revealed shifts in sex-linked H3.3 associations from discrete intergenic sites and broader gene-body domains to promoters in response to the loss of ARID1A. Several sex-linked sites displayed ectopic H3.3 occupancy that did not co-localize with DMC1 (DNA meiotic recombinase 1). This observation suggests a requirement for ARID1A in DMC1 localization to the asynapsed sex chromatids. We conclude that ARID1A-directed H3.3 localization influences meiotic sex chromosome gene regulation and DNA repair.